Professional Documents
Culture Documents
INFECTIONS AND ENVIRONMENT - The emergence of new infections and spread dependent on
migration of Humans to Urban in search of employment and livelihood, It would seem that any
urbanisation drives up the emergence of infectious diseases in those areas, Climate change affects
infectious diseases directly and indirectly. Meteorological factors including temperature,
precipitation, humidity and radiation influence infectious disease by modulating pathogen, host and
transmission pathways. Meteorological disasters such as droughts and floods directly impact the
outbreak and transmission of infectious diseases. Climate change indirectly impacts infectious
diseases by altering the ecological system, including its underlying surface and vegetation
distribution.
NEED FOR AUTOMATION IN INFECTIOUS DISEASES - Microbes are ever evolving with
man we are on the cusp of a dramatic change that will sweep a wave of automation into clinical
microbiology laboratories. Threats faced by ecological changes and ever growing misuse of
antibiotics for trivial conditions
RAPID IDENTIFICATION SAVES LIVES a number of other studies confirm the urgency of rapid
identification of pathogens and its benefit to survival and costs and the effective targeting of
antimicrobial therapy
Limitations of RNTCP Program However the word TB Continues to be least explored disease the
treatment in RNTCP as only National programme to control tuberculosis to be challenged by many
clinicians who take care of patients however on many fronts the physicians continue to have their
own choices and on many fronts empirical treatment continues and the researcher continue to
explore MDR tuberculosis as a threat to the many in the society. Research on new TB diagnostic
tools has been accelerated over the last few years and the diagnostic pipeline has been growing
rapidly as a result
Xpert MTB/RIF Xpert MTB/RIF is an automated, cartridge-based nucleic amplification assay for the
simultaneous detection of TB and rifampicin resistance directly from sputum in under two hours.
The technology is based on the Gene pert platform and was developed as a partnership between the
Foundations for Innovative New Diagnostics (FIND), the test simultaneously detects TB and
rifampicin drug resistance (a reliable indicator for MDR TB) in sputum.
submitting lab within only a few hours, allowing near real-time diagnosis as well as an opportunity
for training in microscopic diagnosis.
NEVER FORGET LABORATORY REPORTING IS THE MIRROR OF strengths and weaknesses Reporting results means most of the process can be understood and assessed by multiple
stakeholders particularly our physicians and surgeons. Furthermore, it enables others to replicate,
develop and improve upon previous practice, leading to improvements in methodologies
Ref 1Emerging infectious diseases and cities, By James Byrne Scientific American
Ref 2Emerging challenges in Infectious Diseases CDC resources
Dr.T.V.Rao MD Professor of Microbiology
Email doctortvrao@gmail.com
The Document made for improving our vision to Diagnostic Microbiology for the
changing needs in Infectious Diseases
Available as open resource on
www.slideshare.com
www.scribd.com
www.likeden.com
www.autourstream.com
Google+ searches